4D Molecular Therapeutics Inc’s recently made public that its Chief Executive Officer Kirn David unloaded Company’s shares for reported $0.3 million on Jun 24 ’24. In the deal valued at $23.10 per share,12,930 shares were sold. As a result of this transaction, Kirn David now holds 1,059,153 shares worth roughly $22.6 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Bizily Scott sold 1,750 shares, generating $41,494 in total proceeds. Upon selling the shares at $23.71, the Chief Legal Officer now owns 1,737 shares.
Before that, Bizily Scott sold 1,750 shares. 4D Molecular Therapeutics Inc shares valued at $44,541 were divested by the Chief Legal Officer at a price of $25.45 per share. As a result of the transaction, Bizily Scott now holds 1,737 shares, worth roughly $37067.58.
Barclays initiated its 4D Molecular Therapeutics Inc [FDMT] rating to an Overweight in a research note published on April 15, 2024; the price target was $459. A number of analysts have revised their coverage, including Barclays’s analysts, who began to cover the stock in mid April with a ‘”an Overweight”‘ rating. RBC Capital Mkts started covering the stock on October 26, 2023. It rated FDMT as “an Outperform”.
Price Performance Review of FDMT
On Monday, 4D Molecular Therapeutics Inc [NASDAQ:FDMT] saw its stock jump 1.67% to $21.34. Over the last five days, the stock has lost -8.22%. 4D Molecular Therapeutics Inc shares have risen nearly 5.33% since the year began. Nevertheless, the stocks have risen 20.36% over the past one year. While a 52-week high of $36.25 was reached on 03/27/24, a 52-week low of $9.44 was recorded on 01/19/24. SMA at 50 days reached $24.39, while 200 days put it at $20.78. A total of 0.52 million shares were traded, compared to the trading of 2.62 million shares in the previous session.
Levels Of Support And Resistance For FDMT Stock
The 24-hour chart illustrates a support level at 20.78, which if violated will result in even more drops to 20.22. On the upside, there is a resistance level at 21.82. A further resistance level may holdings at 22.30. The Relative Strength Index (RSI) on the 14-day chart is 38.23, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.56, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 78.37%. Stochastics%K at 16.20% indicates the stock is a buying.
The most recent change occurred on October 24, 2023 when Cantor Fitzgerald began covering the stock and recommended ‘”an Overweight”‘ rating along with a $32 price target.
